FOR US HEALTHCARE PROFESSIONALS ONLY
Build on the stability you’ve achieved with 3 months of symptom control1*
Evaluated vs placebo, vs INVEGA SUSTENNA®, and in open-label studies
Evaluated in a long-term maintenance trial and established in trials with INVEGA SUSTENNA®
Transition patients to INVEGA TRINZA® and other dosing considerations
A step-by-step guide for administering INVEGA TRINZA®
In a survey of adults with schizophrenia currently taking a long-acting injectable (LAI)
91%
said they would keep doctor appointments between injections if they were on an every-3-month or every-6-month injection given by their HCP.2†
HCP=healthcare professional.
*Before transitioning to INVEGA TRINZA®, patients must be adequately treated with INVEGA SUSTENNA® for at least 4 months (with the last 2 doses being the same).1
†Based on results from a survey of randomly selected adult patients with schizophrenia (N=200). A subgroup of patients were current LAI users (n=41), and among those users, 91% (n=37/41) agreed strongly, mostly, or somewhat (on a 7-point scale) that if they were on a 3- or 6-month medication, they would keep routine appointments with their doctor between injections.2
References: 1. INVEGA TRINZA® [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc. 2. Data on file. Janssen Pharmaceuticals, Inc.